RV-1729 is an inhibitor of the phosphatidylinositol 3-kinase-δ ( PI3Kδ ). RV-1729 identifies inhibition of the PI3K isotype by quantifying the release of phosphatidylinositol 3,4, 5-triphosphate (PIP3) ( IC 50 =12 nM), showing twice the selectivity for PI3Kδ relative to PI3Kγ . RV-1729 is also 16 times more selective to PI3Kα . RV-1729 regulates immune and inflammatory responses by inhibiting PI3Kδ . RV-1729 can be used in studies of asthma and chronic obstructive pulmonary disease (COPD).
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Others | Products > Signaling Pathways > PI3K
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.